Unknown

Dataset Information

0

Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.


ABSTRACT: The peroxisome proliferator-activated receptor alpha (PPARalpha) activator fenofibrate efficiently decreases plasma triglycerides (TG), which is generally attributed to enhanced very low density lipoprotein (VLDL)-TG clearance and decreased VLDL-TG production. However, because data on the effect of fenofibrate on VLDL production are controversial, we aimed to investigate in (more) detail the mechanism underlying the TG-lowering effect by studying VLDL-TG production and clearance using APOE*3-Leiden.CETP mice, a unique mouse model for human-like lipoprotein metabolism. Male mice were fed a Western-type diet for 4 weeks, followed by the same diet without or with fenofibrate (30 mg/kg bodyweight/day) for 4 weeks. Fenofibrate strongly lowered plasma cholesterol (-38%) and TG (-60%) caused by reduction of VLDL. Fenofibrate markedly accelerated VLDL-TG clearance, as judged from a reduced plasma half-life of glycerol tri[(3)H]oleate-labeled VLDL-like emulsion particles (-68%). This was associated with an increased post-heparin lipoprotein lipase (LPL) activity (+110%) and an increased uptake of VLDL-derived fatty acids by skeletal muscle, white adipose tissue, and liver. Concomitantly, fenofibrate markedly increased the VLDL-TG production rate (+73%) but not the VLDL-apolipoprotein B (apoB) production rate. Kinetic studies using [(3)H]palmitic acid showed that fenofibrate increased VLDL-TG production by equally increasing incorporation of re-esterified plasma fatty acids and liver TG into VLDL, which was supported by hepatic gene expression profiling data. We conclude that fenofibrate decreases plasma TG by enhancing LPL-mediated VLDL-TG clearance, which results in a compensatory increase in VLDL-TG production by the liver.

SUBMITTER: Bijland S 

PROVIDER: S-EPMC2919079 | biostudies-other | 2010 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.

Bijland Silvia S   Pieterman Elsbet J EJ   Maas Annemarie C E AC   van der Hoorn José W A JW   van Erk Marjan J MJ   van Klinken Jan B JB   Havekes Louis M LM   van Dijk Ko Willems KW   Princen Hans M G HM   Rensen Patrick C N PC  

The Journal of biological chemistry 20100525 33


The peroxisome proliferator-activated receptor alpha (PPARalpha) activator fenofibrate efficiently decreases plasma triglycerides (TG), which is generally attributed to enhanced very low density lipoprotein (VLDL)-TG clearance and decreased VLDL-TG production. However, because data on the effect of fenofibrate on VLDL production are controversial, we aimed to investigate in (more) detail the mechanism underlying the TG-lowering effect by studying VLDL-TG production and clearance using APOE*3-Lei  ...[more]

Similar Datasets

2010-05-27 | E-GEOD-21211 | biostudies-arrayexpress
2010-05-27 | GSE21211 | GEO
| S-EPMC6171908 | biostudies-literature
| S-EPMC2852959 | biostudies-literature
| S-EPMC5811003 | biostudies-literature
| S-EPMC9240860 | biostudies-literature
| S-EPMC5399386 | biostudies-literature
| S-EPMC7259377 | biostudies-literature
| S-EPMC8554644 | biostudies-literature
| S-EPMC4336596 | biostudies-literature